All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| OLMA / Olema Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| MLTX / MoonLake Immunotherapeutics
|
|
|
|
|
|
|
|
| ACLX / Arcellx, Inc.
|
|
|
|
|
|
|
|
| TRVI / Trevi Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRNX / Crinetics Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| RCKT / Rocket Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RVMD / Revolution Medicines, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| LNTH / Lantheus Holdings, Inc.
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| TWST / Twist Bioscience Corporation
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| ITOS / iTeos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IDYA / IDEAYA Biosciences, Inc.
|
|
|
|
|
|
|
|
| ALXO / ALX Oncology Holdings Inc.
|
|
|
|
|
|
|
|
| RPTX / Repare Therapeutics Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| XENE / Xenon Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| SPRY / ARS Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| JANX / Janux Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MBX / MBX Biosciences, Inc.
|
|
|
|
|
|
|
|
| RARE / Ultragenyx Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VERU / Veru Inc.
|
|
|
|
|
|
|
|
| SLDB / Solid Biosciences Inc.
|
|
|
|
|
|
|
|
| ALKS / Alkermes plc
|
|
|
|
|
|
|
|
| GH / Guardant Health, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CGEM / Cullinan Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CNTX / Context Therapeutics Inc.
|
|
|
|
|
|
|
|
| STOK / Stoke Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RNA / Avidity Biosciences, Inc.
|
|
|
|
|
|
|
|
| ORIC / ORIC Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CMPX / Compass Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NUVB / Nuvation Bio Inc.
|
|
|
|
|
|
|
|
| RLAY / Relay Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RNAC / Cartesian Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TSHA / Taysha Gene Therapies, Inc.
|
|
|
|
|
|
|
|
| HOWL / Werewolf Therapeutics, Inc.
|
|
|
|
|
|
|
|
